Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 3 | 2 | 35 | 26 | 15 |
| Gross Profit | 3 | 2 | 30 | 27 | 10 |
| Operating Expenses | 2,890 | 2,440 | 2,730 | 3,020 | 2,770 |
| Operating Income | -2,887 | -2,438 | -2,695 | -2,994 | -2,755 |
| Other Income | -263 | -302 | -185 | -6,666 | -245 |
| Pre-tax Income | -3,150 | -2,740 | -2,880 | -9,660 | -3,000 |
| Income Tax | 0 | 0 | 210 | 0 | 0 |
| Net Income Continuous | -3,159 | -2,743 | -2,887 | -3,128 | -3,002 |
| Net Income | $-3,159 | $-2,743 | $-2,887 | $-3,128 | $-3,002 |
| EPS Basic Total Ops | -2.60 | -2.30 | -0.25 | -3.20 | -4.10 |
| EPS Basic Continuous Ops | -2.39 | -2.14 | -0.23 | -2.97 | -3.73 |
| EPS Diluted Total Ops | -2.60 | -2.30 | -0.25 | -3.20 | -4.10 |
| EPS Diluted Continuous Ops | -2.39 | -2.14 | -0.23 | -2.97 | -3.73 |
| EBITDA(a) | $-2,797 | $-2,338 | $-2,605 | $-2,914 | $-2,725 |